Functional characteristics of HIV-1 subtype C compatible with increased heterosexual transmissibility

AIDS

Volumn 23, Issue 9, 2009, Pages 1047-1057

  Walter, Brandon L ^a   Armitage, Andrew E ^b   Graham, Stephen C ^c   De Oliveira, Tulio ^d   Skinhøj, Peter ^e   Jones, E Yvonne ^c   Stuart, David I ^c   McMichael, Andrew J ^b   Chesebro, Bruce ^a   Iversen, Astrid K ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^e Rigshospitalet   (Denmark)

Author keywords

CCR5; Cervix; Evolution; HIV 1; Phylogeny; Subtype A; Subtype C; Transmission

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN GP 120;

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENVELOPE GENE; EVOLUTIONARY ADAPTATION; FEMALE; GENE DELETION; GENETIC CONSERVATION; HELA CELL; HETEROSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1 TYPE A; HUMAN IMMUNODEFICIENCY VIRUS 1 TYPE B; HUMAN IMMUNODEFICIENCY VIRUS 1 TYPE C; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; VIRAL GENETICS; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANTIGENS, CD4; CERVIX UTERI; FEMALE; HETEROSEXUALITY; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; SEQUENCE ANALYSIS; SEXUALLY TRANSMITTED DISEASES, VIRAL; VIRUS REPLICATION;

EID: 67651100933     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832a1806     Document Type: Article

References (55)

1. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 2002; 29:184-190.
2. Morison L, Weiss HA, Buve A, Caraël M, Abega SC, Kaona F, et al. Commercial sex and the spread of HIV in four cities in sub-Saharan Africa. AIDS 2001; 15 (Suppl 4):S61-S69.
3. Shankarappa R, Chatterjee R, Learn GH, Neogi D, Ding M, Roy P, et al. Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J Virol 2001; 75:10479-10487.
4. Yu XF, Wang X, Mao P, Wang S, Li Z, Zhang J, et al. Characterization of HIV type 1 heterosexual transmission in Yunnan, China. AIDS Res Hum Retroviruses 2003; 19:1051-1055.
5. Soares EA, Martinez AM, Souza TM, Santos AF, Da Hora V, Silveira J, et al. HIV-1 subtype C dissemination in southern Brazil. AIDS 2005; 19 (Suppl 4):S81-S86.
6. Carswell W. HIV in South Africa. Lancet 1993; 342:132.
7. Hunter DJ. AIDS in sub-Saharan Africa: the epidemiology of heterosexual transmission and the prospects for prevention. Epidemiology 1993; 4:63-72.
8. Morison L, Buve A, Zekeng L, Heyndrickx L, Anagonou S, Musonda R, et al. HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa. AIDS 2001; 15 (Suppl 4): S109-S116.
9. Renjifo B, Gilbert P, Chaplin B, Msamanga G, Mwakagile D, Fawzi W, et al. Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS 2004; 18:1629-1636.
10. John-Stewart GC, Nduati RW, Rousseau CM, Mbori-Ngacha DA, Richardson BA, Rainwater S, et al. Subtype C is associated with increased vaginal shedding of HIV-1. J Infect Dis 2005; 192:492-496.
11. O'Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet 2004; 36:565-574.
12. Chohan B, Lang D, Sagar M, Korber B, Lavreys L, Richardson B, et al. Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J Virol 2005; 79:6528-6531.
13. Li B, Decker JM, Johnson RW, Bibollet-Ruche F, Wei X, Mulenga J, et al. Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1. J Virol 2006; 80:5211-5218.
14. Sagar M, Wu X, Lee S, Overbaugh J. Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J Virol 2006; 80:9586-9598.
15. Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, Denham SA, et al. Envelope-constrained neutralizationsensitive HIV-1 after heterosexual transmission. Science 2004; 303:2019-2022.
16. Frost SD, Liu Y, Pond SL, Chappey C, Wrin T, Petropoulos CJ, et al. Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. J Virol 2005; 79:6523-6527.
17. Iversen AK, Larsen AR, Jensen T, Fugger L, Balslev U, Wahl S, et al. Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. J Infect Dis 1998; 177:1214-1220.
18. Iversen AK, Fugger L, Eugen-Olsen J, Balslev U, Jensen T, Wahl S, et al. Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretion. J Infect Dis 1998; 178:1334-1342.
19. Iversen AK, Learn GH, Fugger L, Gerstoft J, Mullins JI, Skinhoj P. Presence of multiple HIV subtypes and a high frequency of subtype chimeric viruses in heterosexually infected women. J Acquir Immune Defic Syndr 1999; 22:325-332.
20. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986; 59:284-291.
21. Chesebro B, Wehrly K, Nishio J, Perryman S. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 1992; 66:6547-6554.
22. Chesebro B, Nishio J, Perryman S, Cann A, O'Brien W, Chen IS, et al. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J Virol 1991; 65:5782-5789.
23. Toohey K, Wehrly K, Nishio J, Perryman S, Chesebro B. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 1995; 213:70-79.
24. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 1998; 72:2855-2864.
25. Walter BL, Wehrly K, Swanstrom R, Platt E, Kabat D, Chesebro B. Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophages. J Virol 2005; 79:4828-4837.
26. * and other methods). Sunderland, MA; 1999.
27. Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003; 52:696-704.
28. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-1599.
29. Huang CC, Tang M, Zhang MY, Majeed S, Montabana E, Stanfield RL, et al. Structure of a V3-containing HIV-1 gp120 core. Science 2005; 310:1025-1028.
30. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004; 60:2126-2132.
31. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A 2001; 98:10037-10041.
32. Yang ZR, Thomson R, McNeil P, Esnouf RM. RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins. Bioinformatics 2005; 21:3369-3376.
33. Iversen AK, Learn GH, Skinhoj P, Mullins JI, McMichael AJ, Rambaut A. Preferential detection of HIV subtype C over subtype A in cervical cells from a dually infected woman. AIDS 2005; 19:990-993.
34. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17:657-700.
35. Cormier EG, Dragic T. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J Virol 2002; 76:8953-8957.
36. Nabatov AA, Pollakis G, Linnemann T, Kliphius A, Chalaby MI, Paxton WA. Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC che-mokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies. J Virol 2004; 78:524-530.
37. Huang CC, Lam SN, Acharya P, Tang M, Xiang SH, Hussan SS, et al. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 2007; 317:1930-1934.
38. Schulz GE. Molecular mechanism of biological recognition. New York: Elsevier/North-Holland Biomedical Press; 1979.
39. Janssens W, Buve A, Nkengasong JN. The puzzle of HIV-1 subtypes in Africa. AIDS 1997; 11:705-712.
40. Walker PR, Worobey M, Rambaut A, Holmes EC, Pybus OG. Epidemiology: sexual transmission of HIV in Africa. Nature 2003; 422:679.
41. Hladik F, Lentz G, Delpit E, McElroy A, McElrath MJ. Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5R Th1 phenotype. J Immunol 1999; 163:2306-2313.
42. Patterson BK, Landay A, Andersson J, Brown C, Behbahani H, Jiyamapa D, et al. Repertoire ofchemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol 1998; 153:481-490.
43. Hladik F, Liu H, Speelmon E, Livingston-Rosanoff D, Wilson S, Sakchalathorn P, et al. Combined effect of CCR5-delta32 heterozygosity and the CCR5 promoter polymorphism-2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission. J Virol 2005; 79:11677-11684.
44. Thomas SM, Tse DB, Ketner DS, Rochford G, Meyer DA, Zade DD, et al. CCR5 expression and duration of high risk sexual activity among HIV-seronegative men who have sex with men. AIDS 2006; 20:1879-1883.
45. Hoffman TL, MacGregor RR, Burger H, Mick R, Doms RW, Collman RG. CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status. J Infect Dis 1997; 176:1093-1096.
46. Laurent C, Bourgeois A, Faye MA, Mougnutou R, Seydi M, Gueye M, et al. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02-AG strain and patients not infected with CRF02-AG, in western and west-central Africa: a four-year prospective multicenter study. J Infect Dis 2002; 186:486-492.
47. Westby M, Smith-Burchnell C, Mori J, Lewis M, Mosley M, Stockdale M, et al. Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry. J Virol 2007; 81:2359-2371.
48. Kuhmann SE, Pugach P, Kunstman KJ, Taylor J, Stanfield RL, Snyder A, et al. Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor. J Virol 2004; 78:2790-2807.
49. McClure CP, Tighe PJ, Robins RA, Bansal D, Bowman CA, Kingston M, et al. HIV coreceptor and chemokine ligand gene expression in the male urethra and female cervix. AIDS 2005; 19:1257-1265.
50. Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, Eschenbach D, et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007; 26:257-270.
51. Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O. Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol 2007; 81:1000-1012.
52. Prakash M, Patterson S, Gotch F, Kapembwa MS. Ex vivo analysis of HIV-1 co-receptors at the endocervical mucosa of women using oral contraceptives. BJOG 2004; 111:1468-1470.
53. Wain LV, Bailes E, Bibollet-Ruche F, Decker JM, Keele BF, Van Heuverswyn F, et al. Adaptation of HIV-1 to its human host. Mol Biol Evol 2007; 24:1853-1860.
54. Lockett SF, Alonso A, Wyld R, Martin MP, Robertson JR, Gore SM, et al. Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission. J Infect Dis 1999; 180:614-621.
55. Centlivre M, Sala M, Wain-Hobson S, Berkhout B. In HIV-1 pathogenesis the dice is cast during primary infection. AIDS 2007; 21:1-11.